Drug Safety Bills on Slow Track Through Congress
By Mari Serebrov
Monday, February 27, 2012
WASHINGTON – Fears of another heparin fiasco and the reality of stolen and counterfeit drugs entering the U.S. supply chain have fueled several new bills in Congress, but the wheels of the legislative process are turning slowly.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.